UMM logo

Maryland Heart Center

Clinical Cardiovascular Electrophysiology Training Program

Mission Statement | Program Objectives | Curriculum | Faculty Supervision | Recommended References and Texts | Application

 

Program Objectives

To fully learn the indications, contradictions, risks, limitations, sensitivity, specificity, and predictive accuracy, and appropriate techniques for evaluating patients with a wide variety of rhythm disorders including:

  1. Sinus node dysfunction;
    1. Differentiation of sinus node dysfunction from chronotropic incompetence
    2. Role of noninvasive testing (stress tests and Holter monitoring)
    3. Role of invasive testing and measured parameters (SACT, SNRT, etc.)

  2. AV node dysfunction;
    1. Role of noninvasive evaluation (Holter, ECG, Event and Loop Recorders)
    2. Use of invasive testing (Intracardiac intervals, AV node curves, Implantable Loop Recorders etc.)
    3. Appropriate use of pharmacologic agents
    4. Indications for temporary and permanent pacemakers

  3. Intraventricular conduction disorders
    1. Role of noninvasive evaluation (Holter, ECG, Event and Loop Recorders, Exercise Testing)
    2. Use of invasive testing (Intracardiac intervals, Implantable Loop Recorders)
    3. Appropriate use of pharmacologic agents
    4. Indications for temporary and permanent pacemakers

  4. Atrial Flutter
    1. Acute management (pharmacologic, electrical)
    2. Chronic management (pharmacologic, electrical)
    3. Ablation (indications, techniques, complications)

  5. Atrial Fibrillation
    1. Acute management (pharmacologic, electrical)
    2. Chronic management (pharmacologic, electrical)
    3. Ablation (indications, techniques, complications
    4. Device therapy (indications, pacemakers, defibrillators)
    5. Surgical therapy (indications, complications)

  6. Other supraventricular arrhythmias;
    1. Role of noninvasive evaluation (ECG, Holter, Event Recorder)
    2. Use of invasive evaluation including indications, mapping techniques including newer 3 dimensional mapping systems and intracardiac ultrasound
    3. Pharmacologic management
    4. Ablation (indications, techniques, complications, etc)

  7. Ventricular arrhythmias;
    1. Acute management (pharmacological, electrical)
    2. Role of noninvasive management (ECG, Holter)
    3. Use of invasive evaluation (indications, techniques for mapping, etc)
    4. Chronic pharmacologic management
    5. Implantable defibrillators (indications, techniques for implantation, complications)

  8. Unexplained syncope
    1. Role of noninvasive monitoring (ECG, Holter, Event/Loop recorder)
    2. Role of Tilt table testing
    3. Role of invasive electrophysiological studies
    4. Role of implantable loop recorders
    5. Role of other evaluations (vascular, neurologic, etc)

  9. Aborted sudden cardiac death
    1. Acute management (pharmacological, electrical)
    2. Role of noninvasive management
    3. Role of invasive evaluation (electrophysiological, angiography)
    4. Implantable defibrillators (indications, techniques for implantation, complications)
    5. Chronic pharmacologic management

  10. Neurocardiogenic syncope and related disorders
    1. Diagnosis
    2. Pharmacologic management
    3. Role of device therapy

  11. Long QT syndrome
    1. Diagnosis
    2. Treatment (pharmacologic, devices)
    3. Cellular mechanism, molecular genetics, family counseling

  12. Hypertrophic cardiomyopathy
    1. Diagnosis
    2. Treatment (pharmacologic, devices)
    3. Genetics and cellular mechanisms

  13. Postoperative arrhythmias
    1. Acute management (pharmacologic, electrical, devices)
    2. Long term implications

  14. Management of arrhythmias in pediatric patients with Pacemakers
    1. Indications
    2. Techniques for implantation
    3. Complications
    4. Long-term management
    5. Newer indications and techniques (dual atrial, biventricular)

  15. Implantable defibrillators
    1. Indications
    2. Techniques for implantation
    3. Complications
    4. Long-term management
    5. Newer indications and techniques (biventricular for CHF, for atrial fibrillation)

  16. Non-invasive risk stratification
    1. Signal averaged ECG
    2. T-wave alternans
    3. Measures of repolarization (wavelet analysis of T-waves)

  17. Outpatient evaluation and management
    1. Initial evaluation and long-term follow-up of patients with arrhythmias or symptoms (i.e palpitations)
    2. Pacemaker follow-up
    3. ICD follow-up

Please call if you would like to make an appointment or talk to someone about our services. Patients dial 1-800-492-5538 or 410-328-5842, physicians dial 410-328-6622 or 1-800-318-1019.